In last trading session, Immunic Inc (NASDAQ:IMUX) saw 1.81 million shares changing hands with its beta currently measuring 1.95. Company’s recent per share price level of $1.18 trading at $0.13 or 12.38% at ring of the bell on the day assigns it a market valuation of $106.29M. That closing price of IMUX’s stock is at a discount of -78.81% from its 52-week high price of $2.11 and is indicating a premium of 22.03% from its 52-week low price of $0.92.
For Immunic Inc (IMUX), analysts’ consensus is at an average recommendation of Buy while assigning it a mean rating of 1.00. Splitting up the data highlights that, out of 3 analysts covering the stock, 0 rated the stock as a Sell while 0 recommended an Overweight rating for the stock. 0 suggested the stock as a Hold whereas 3 see the stock as a Buy. 0 analyst(s) advised it as an Underweight. The company is expected to be making an EPS of -0.24 in the current quarter.
Immunic Inc (NASDAQ:IMUX) trade information
Upright in the green during last session for gaining 12.38%, in the last five days IMUX remained trading in the green while hitting it’s week-highest on Thursday, 02/20/25 when the stock touched $1.18 price level, adding 0.84% to its value on the day. Immunic Inc’s shares saw a change of 18.00% in year-to-date performance and have moved 25.80% in past 5-day. Immunic Inc (NASDAQ:IMUX) showed a performance of 24.21% in past 30-days.
Wall Street analysts have assigned a consensus price target of 5 to the stock, which implies a rise of 76.4% to its current value. Analysts have been projecting 5 as a low price target for the stock while placing it at a high target of 5. It follows that stock’s current price would drop -323.73% in reaching the projected high whereas dropping to the targeted low would mean a loss of -323.73% for stock’s current value.
Weighing up company’s earnings over the past 5-year and in the next 5-year periods, we find the company posting an annual earnings growth rate of 31.12% during past 5 years. In 2025, company’s earnings growth rate is likely to be around 54.88% while estimates for its earnings growth in next 5 years are of 32.90%.
Immunic Inc (NASDAQ:IMUX)’s Major holders
BVF INC/IL is the top institutional holder at IMUX for having 8.9 million shares of worth $9.88 million. And as of 2024-06-30, it was holding 9.15 of the company’s outstanding shares.
The second largest institutional holder is AVIDITY PARTNERS MANAGEMENT LP, which was holding about 8.9 million shares on 2024-06-30. The number of shares represents firm’s hold over 9.15 of outstanding shares, having a total worth of $9.88 million.
On the other hand, Vanguard Total Stock Market Index Fund and Vanguard Extended Market Index Fund are the top two Mutual Funds which own company’s shares. As of Sep 30, 2024 , the former fund manager was holding 2.63 shares of worth $3.1 million or 2.92% of the total outstanding shares. The later fund manager was in possession of 1.87 shares on Sep 30, 2024 , making its stake of worth around $2.21 million in the company or a holder of 2.08% of company’s stock.
